Genmab A/S (GMAB)
NASDAQ·Healthcare·Biotechnology
$34.80
-1.21%
Mkt Cap $16.79B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (22 analysts)
$38.25
Range $32.00 – $43.00
Implied Upside
+9.9%
Consensus $38.25 vs current $34.80
NASDAQ·Healthcare·Biotechnology
$34.80
-1.21%
Mkt Cap $16.79B
Buy
1
Hold
0
Sell
0
Price Target (22 analysts)
$38.25
Range $32.00 – $43.00
+9.9%
Consensus $38.25 vs current $34.80